BASEL (dpa-AFX) - Swiss drug giant Novartis AG (NVS) is considering selling its struggling eye care division, but all options - including a turnaround - are still on the table, Swiss weekly SonntagsZeitung reported citing an interview with the firm's Chairman Joerg Reinhardt.
The company has blamed a failure to innovate and inconsistent customer service for the problems at Alcon, a business that Novartis gradually bought from Nestle in deals totaling $51 billion.
Copyright RTT News/dpa-AFX
© 2016 AFX News
